Market value added (MVA) is the difference between a firm fair value and its invested capital. MVA is a measure of the value a company has created in excess of the resources already committed to the enterprise.
Paying user area
Try for free
Becton, Dickinson & Co. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Becton, Dickinson & Co. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
MVA
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 Fair value of debt. See details »
2 Invested capital. See details »
- Market (fair) value of BD
- The market value showed a pronounced upward trend from September 2016 through September 2019, rising from $48,294 million to a peak of $91,399 million. However, it declined to $86,074 million in 2020 before recovering slightly to $88,932 million in 2021.
- Invested capital
- Invested capital exhibited consistent growth from 2016 to 2018, increasing from $22,258 million to $47,282 million. Subsequently, it decreased somewhat to $45,181 million in 2019, followed by minor fluctuations, ending at $45,278 million in 2021. This indicates a stabilization in capital investment after noticeable expansion in earlier years.
- Market value added (MVA)
- Market value added rose steadily between 2016 and 2019, climbing from $26,036 million to $46,218 million, signaling increasing market appreciation over invested capital. A decline occurred in 2020 to $39,762 million, paralleling the dip in market value, before recovering to $43,654 million in 2021. Overall, MVA remains significantly higher in later years compared to the initial period, suggesting sustained value creation despite recent volatility.
MVA Spread Ratio
Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Market value added (MVA)1 | |||||||
Invested capital2 | |||||||
Performance Ratio | |||||||
MVA spread ratio3 | |||||||
Benchmarks | |||||||
MVA Spread Ratio, Competitors4 | |||||||
Abbott Laboratories | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 MVA. See details »
2 Invested capital. See details »
3 2021 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × ÷ =
4 Click competitor name to see calculations.
- Market Value Added (MVA)
- The market value added showed an overall upward trend from 2016 to 2021, increasing from approximately 26,036 million USD in 2016 to 43,654 million USD in 2021. Notably, there was a significant rise between 2016 and 2019, reaching a peak of 46,218 million USD in 2019. This was followed by a decline in 2020 to 39,762 million USD, after which MVA increased again in 2021.
- Invested Capital
- Invested capital experienced considerable growth during the analyzed period, starting at 22,258 million USD in 2016 and rising steadily to a peak of 47,282 million USD in 2018. From 2018 to 2021, the invested capital showed some fluctuation but remained relatively stable around the range of 45,000 to 46,000 million USD.
- MVA Spread Ratio
- The MVA spread ratio, representing the efficiency of value generation relative to invested capital, showed variability over time. It began very high at 116.97% in 2016, indicating strong value generation. This ratio decreased significantly in the following years, reaching its lowest point at 83.54% in 2018. Thereafter, it recovered somewhat, peaking at 102.29% in 2019 before fluctuating again and settling at 96.41% by 2021. The variations suggest fluctuating performance in maximization of market value relative to capital invested.
MVA Margin
Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Market value added (MVA)1 | |||||||
Revenues | |||||||
Performance Ratio | |||||||
MVA margin2 | |||||||
Benchmarks | |||||||
MVA Margin, Competitors3 | |||||||
Abbott Laboratories | |||||||
CVS Health Corp. | |||||||
Elevance Health Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 MVA. See details »
2 2021 Calculation
MVA margin = 100 × MVA ÷ Revenues
= 100 × ÷ =
3 Click competitor name to see calculations.
- Market Value Added (MVA)
- The market value added exhibited a general upward trend from 2016 through 2019, increasing from $26,036 million to $46,218 million, reflecting significant growth in the company’s market valuation. However, in 2020, there was a decline to $39,762 million, indicating a temporary reduction in market value, possibly linked to external economic factors. This value partially recovered in 2021, rising to $43,654 million, suggesting a rebound in market confidence.
- Revenues
- Revenue figures revealed fluctuations over the analyzed period. Initially, revenues slightly decreased from $12,483 million in 2016 to $12,093 million in 2017. Subsequently, there was a notable increase to $15,983 million in 2018 and further growth to $17,290 million in 2019. Revenues slightly decreased to $17,117 million in 2020, coinciding with the MVA decline. In 2021, revenues surged to $20,248 million, reaching the highest level in the observed period and indicating strong operational performance and growth.
- MVA Margin
- The MVA margin, representing the ratio of market value added to revenues, showed significant variability. It peaked at 298.56% in 2017 following a revenue dip, indicating an overproportionate increase in market valuation relative to revenues. Thereafter, it declined steadily to 215.6% in 2021. Despite fluctuations, the margin remained well above 200%, suggesting sustained strong market valuation relative to revenue generation across the years.